Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGL Agilon Health	$2.13 -1.8%	$2.31	$1.50 ▼ $7.62	$881.71M	0.16	5.16 million shs	3.07 million shs
CDNA CareDx	$11.92 +0.9%	$18.30	$10.96 ▼ $34.84	$663.71M	2.19	1.11 million shs	5.72 million shs
PNTG The Pennant Group	$23.43 -2.0%	$27.89	$21.18 ▼ $37.13	$807.63M	1.51	237,071 shs	393,082 shs
TOI Oncology Institute	$3.50 -4.1%	$2.73	$0.13 ▼ $3.83	$312.31M	0.02	1.22 million shs	2.66 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGL Agilon Health	+0.92%	-5.62%	+3.31%	-45.70%	-70.31%
CDNA CareDx	-38.49%	-42.75%	-39.50%	-32.97%	-35.46%
PNTG The Pennant Group	+0.63%	-7.36%	-14.21%	-8.50%	-12.00%
TOI Oncology Institute	+13.00%	+27.18%	+55.98%	+68.98%	+578.44%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGL Agilon Health	2.433 of 5 stars	4.1	2.0	0.0	2.4	0.0	0.6
CDNA CareDx	4.1365 of 5 stars	3.3	1.0	4.2	2.6	0.8	1.9
PNTG The Pennant Group	3.3593 of 5 stars	3.3	3.0	0.0	2.1	2.5	1.9
TOI Oncology Institute	2.0252 of 5 stars	3.8	2.0	0.0	2.5	0.8	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGL Agilon Health	2.17	Hold	$4.71	121.33% Upside
CDNA CareDx	2.67	Moderate Buy	$29.33	146.09% Upside
PNTG The Pennant Group	2.60	Moderate Buy	$33.80	44.26% Upside
TOI Oncology Institute	3.50	Strong Buy	$6.50	85.71% Upside

Current Analyst Ratings Breakdown

Latest TOI, CDNA, AGL, and PNTG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/18/2025	CDNA CareDx	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $26.00
7/16/2025	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$32.00 ➝ $28.00
7/16/2025	TOI Oncology Institute	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$6.00
7/15/2025	TOI Oncology Institute	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/9/2025	AGL Agilon Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$5.00 ➝ $3.00
6/10/2025	PNTG The Pennant Group	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$35.00
6/3/2025	PNTG The Pennant Group	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$30.00 ➝ $31.00
5/15/2025	TOI Oncology Institute	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$7.00
5/13/2025	AGL Agilon Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$6.00 ➝ $5.00
5/12/2025	PNTG The Pennant Group	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$28.00 ➝ $32.00
5/8/2025	AGL Agilon Health	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$2.00 ➝ $3.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGL Agilon Health	$6.06B	0.15	N/A	N/A	$1.14 per share	1.87
CDNA CareDx	$333.79M	1.99	$0.84 per share	14.12	$7.06 per share	1.69
PNTG The Pennant Group	$695.24M	1.16	$0.91 per share	25.77	$9.08 per share	2.58
TOI Oncology Institute	$393.41M	0.79	N/A	N/A	$0.05 per share	70.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGL Agilon Health	-$260.15M	-$0.59	N/A	N/A	N/A	-4.04%	-45.47%	-12.76%	8/5/2025 (Estimated)
CDNA CareDx	$52.55M	$1.15	10.37	N/A	N/A	19.79%	21.16%	14.25%	7/30/2025 (Estimated)
PNTG The Pennant Group	$22.56M	$0.76	30.83	26.63	2.02	3.40%	10.73%	4.00%	8/5/2025 (Estimated)
TOI Oncology Institute	-$64.66M	-$0.70	N/A	∞	N/A	-15.38%	-445.02%	-34.13%	8/12/2025 (Estimated)

Latest TOI, CDNA, AGL, and PNTG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	N/A	TOI Oncology Institute	-$0.13	N/A	N/A	N/A	$112.56 million	N/A
8/5/2025	Q2 2025	AGL Agilon Health	-$0.11	N/A	N/A	N/A	$1.47 billion	N/A
8/5/2025	Q2 2025	PNTG The Pennant Group	$0.26	N/A	N/A	N/A	$210.59 million	N/A
7/30/2025	Q2 2025	CDNA CareDx	$0.12	N/A	N/A	N/A	$90.72 million	N/A
5/14/2025	Q1 2025	TOI Oncology Institute	N/A	-$0.18	N/A	-$0.21	N/A	$104.41 million
5/6/2025	Q1 2025	AGL Agilon Health	-$0.01	$0.03	+$0.04	$0.03	$1.50 billion	$1.53 billion
4/30/2025	Q1 2025	CDNA CareDx	$0.06	$0.09	+$0.03	-$0.19	$84.56 million	$84.69 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGL Agilon Health	N/A	N/A	N/A	N/A	N/A
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A
TOI Oncology Institute	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGL Agilon Health	N/A	1.20	1.20
CDNA CareDx	N/A	4.11	3.84
PNTG The Pennant Group	0.81	1.41	1.41
TOI Oncology Institute	14.58	1.79	1.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGL Agilon Health	N/A
CDNA CareDx	N/A
PNTG The Pennant Group	85.88%
TOI Oncology Institute	36.86%

Insider Ownership

Company	Insider Ownership
AGL Agilon Health	3.57%
CDNA CareDx	4.40%
PNTG The Pennant Group	5.40%
TOI Oncology Institute	8.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGL Agilon Health	1,076	413.95 million	399.17 million	Not Optionable
CDNA CareDx	740	55.68 million	53.23 million	Optionable
PNTG The Pennant Group	7,000	34.47 million	32.61 million	Optionable
TOI Oncology Institute	660	89.23 million	81.65 million	Not Optionable

TOI, CDNA, AGL, and PNTG Headlines

Recent News About These Companies

Q2 Earnings Estimate for TOI Issued By B. Riley

July 18 at 8:46 AM | marketbeat.com

B. Riley Begins Coverage on Oncology Institute (NASDAQ:TOI)

July 18 at 4:05 AM | americanbankingnews.com

Oncology Institute (NASDAQ:TOI) Stock Rating Upgraded by B. Riley

July 18 at 2:18 AM | americanbankingnews.com

Three weeks on, Kidwai’s sole MRI machine still not working

July 17 at 8:49 PM | timesofindia.indiatimes.com

Oncology Institute (NASDAQ:TOI) Raised to Strong-Buy at B. Riley

July 17 at 5:49 AM | marketbeat.com

B. Riley Securities Initiates Coverage of Oncology Institute (TOI) with Buy Recommendation

July 17 at 3:25 AM | msn.com

B. Riley Initiates Coverage on Oncology Institute (NASDAQ:TOI)

July 16 at 9:02 AM | marketbeat.com

Topicus.com Inc. Announces Release Date forÂ Second Quarter Results

July 14, 2025 | globenewswire.com

The Oncology Institute Names Kristin England as Chief Administrative Officer

July 14, 2025 | globenewswire.com

The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members

July 9, 2025 | finance.yahoo.com

Oncology Institute (NASDAQ:TOI) Trading Up 7.3% - Here's Why

July 2, 2025 | marketbeat.com

The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada

June 30, 2025 | globenewswire.com

Investing in Oncology Institute (NASDAQ:TOI) a year ago would have delivered you a 376% gain

June 29, 2025 | finance.yahoo.com

A game-changer in cancer research? South Korean scientists reprogram tumour cells without chemotherapy or radiation

June 25, 2025 | msn.com

TOI - The Oncology Institute Inc Sustainability - Morningstar

June 24, 2025 | morningstar.comM

Approvals for oncology procedures rise under Ayushman Bharat Arogya Karnataka scheme

June 10, 2025 | timesofindia.indiatimes.com

The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in Stock

June 10, 2025 | insidertrades.com

Insider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 1,976,137 Shares of Stock

June 6, 2025 | insidertrades.com

The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes

June 3, 2025 | globenewswire.com

Insider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 203,532 Shares of Stock

May 23, 2025 | insidertrades.com

Oncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)

May 16, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TOI, CDNA, AGL, and PNTG Company Descriptions

Agilon Health NYSE:AGL

$2.13 -0.04 (-1.84%)

Closing price 03:59 PM Eastern

Extended Trading

$2.14 +0.01 (+0.47%)

As of 04:25 PM Eastern

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

CareDx NASDAQ:CDNA

$11.92 +0.11 (+0.93%)

Closing price 04:00 PM Eastern

Extended Trading

$11.95 +0.03 (+0.25%)

As of 04:36 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

The Pennant Group NASDAQ:PNTG

$23.43 -0.48 (-2.01%)

Closing price 04:00 PM Eastern

Extended Trading

$23.42 -0.02 (-0.06%)

As of 04:10 PM Eastern

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Oncology Institute NASDAQ:TOI

$3.50 -0.15 (-4.11%)

Closing price 04:00 PM Eastern

Extended Trading

$3.56 +0.06 (+1.71%)

As of 04:36 PM Eastern

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time